Biolife Solutions (BLFS) Non-Current Assets (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Non-Current Assets of $267.7 million for Q1 2026, up 1.39% year-over-year from $264.0 million in Q1 2025, and down 0.61% quarter-over-quarter from $269.3 million in Q4 2025.
Biolife Solutions (BLFS) Non-Current Assets (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Non-Current Assets for 17 consecutive years, with $267.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 1.39% year-over-year to $267.7 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 2.69% YoY), while the FY2025 annual figure was $269.3 million, up 7.42% from the prior year.
- Non-Current Assets retreated to $267.7 million in Q1 2026 per BLFS's latest filing, from $269.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $425.3 million in Q1 2022 and bottomed at $250.7 million in Q4 2024.
- Historically, Non-Current Assets has averaged $300.1 million across 5 years, with a median of $292.1 million in 2023.
- On a YoY basis, Non-Current Assets climbed as much as 244.43% in 2022 and fell as far as 27.19% in 2022.
- Biolife Solutions' Non-Current Assets stood at $311.8 million in 2022, then decreased by 6.31% to $292.1 million in 2023, then fell by 14.17% to $250.7 million in 2024, then rose by 7.42% to $269.3 million in 2025, then declined by 0.61% to $267.7 million in 2026.
- Business Quant data shows BLFS's Non-Current Assets at $267.7 million in Q1 2026, $269.3 million in Q4 2025, and $265.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.61 Bn | 129.40 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.80 Bn | 34.45 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.87 Bn | 32.41 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 28.89 Bn | 26.21 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.07 Bn | 24.63 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.33 Bn | 14.92 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Biolife Solutions | 1.80 Bn | 1.72 Bn | 18.29 Mn | 312.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 312.30 Mn |
| Mar 31, 2026 | 267.68 Mn |
| Dec 31, 2025 | 269.32 Mn |
| Sep 30, 2025 | 265.52 Mn |
| Jun 30, 2025 | 261.81 Mn |
| Mar 31, 2025 | 264.01 Mn |
| Dec 31, 2024 | 250.73 Mn |
| Sep 30, 2024 | 292.27 Mn |
| Jun 30, 2024 | 286.78 Mn |
| Mar 31, 2024 | 289.90 Mn |
| Dec 31, 2023 | 292.11 Mn |
| Sep 30, 2023 | 294.33 Mn |
| Jun 30, 2023 | 312.87 Mn |
| Mar 31, 2023 | 313.68 Mn |
| Dec 31, 2022 | 311.78 Mn |
| Sep 30, 2022 | 351.81 Mn |
| Jun 30, 2022 | 352.32 Mn |
| Mar 31, 2022 | 425.31 Mn |
| Dec 31, 2021 | 428.20 Mn |
| Sep 30, 2021 | 428.89 Mn |